Anúncio
Anúncio
ANEB
Anebulo Pharmaceuticals, Inc. Common Stock
1.10
USDPatrocinado
-0.08
-7.14%
09 de jan., 15:56 UTC -5
Encerrado
Pós-Mercado
1.14
+0.03
+3.08%
Relatórios de Lucros ANEB
Rácio de surpresa positiva
ANEB separação 9 de 17 últimas estimativas.
53%
Próximo Relatório
Data do Próximo Relatório
06 de fev. de 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.13
Mudanças implicadas de Q1 26 (Revenue/ EPS)
--
/+160.00%
Mudanças implicadas de Q2 25 (Revenue/ EPS)
--
/+44.44%
Anebulo Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On 13 de nov. de 2025, ANEB reported earnings of -0.05 USD per share (EPS) for Q1 26, beating the estimate of -0.12 USD, resulting in a 59.15% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a -3.80% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analistas forecast an EPS of -0.13 USD, with revenue projected to reach -- USD, implying an aumentar of 160.00% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Anebulo Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Anebulo Pharmaceuticals, Inc. Common Stock reported EPS of -$0.05, beating estimates by 59.15%, and revenue of --, -- -- expectations.
How did the market react to Anebulo Pharmaceuticals, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -3.8%, changed from $2.37 before the earnings release to $2.28 the day after.
When is Anebulo Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for 06 de fev. de 2026.
What are the forecasts for Anebulo Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 3
analistas, Anebulo Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.13 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio